Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
GTI Energy

Related Posts

Lunar Mining Set to Favor Established Miners Over...

November 11, 2025

Pinnacle Provides Reminder on the Company’s Upcoming Annual...

January 10, 2025

10 Generative AI Stocks to Watch as ChatGPT...

September 5, 2025

Seegnal Inc. Announces Extension of Maccabi Health Services...

September 9, 2025

$8 Million Capital Raise to Commence Bringing the...

May 14, 2024

Chemical assay confirms high-grade uranium

September 17, 2025

Silver47 Commences Trading on OTC Markets Under the...

March 10, 2025

Orla to Buy Musselwhite Gold Mine from Newmont...

November 20, 2024

Standard Uranium

November 13, 2025

Transformational Acquisition of the High-Grade Elizabeth Hill Silver...

March 24, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • DAVID MARCUS: Erika Kirk is the mother squabbling conservatives need

      December 22, 2025
    • Rapper Nicki Minaj teams up with new Turning Point USA leader Erika Kirk for Q&A session

      December 22, 2025
    • DOJ restores Trump photo to Epstein files after determining no victims depicted

      December 22, 2025
    • DHS responds after reports CISA chief allegedly failed polygraph for classified intel access

      December 22, 2025
    • Expanded ExxonMobil Award Validates RemSense Strategy

      December 22, 2025

    Categories

    • Business (1,144)
    • Investing (3,742)
    • Politics (4,540)
    • Stocks (1,155)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved